                         SEQUENCE LISTING

<110>  President and Fellows of Harvard College
 
<120>  METHODS AND REAGENTS FOR THE ASSESSMENT OF GESTATIONAL DIABETES

<130>  00742-253WO4

<150>  61/945,860
<151>  2014-02-28

<150>  61/946,373
<151>  2014-02-28

<150>  61/911,306
<151>  2013-12-03

<160>  11    

<170>  PatentIn version 3.5

<210>  1
<211>  77
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  1

Leu Gln Cys Tyr Asn Cys Pro Asn Pro Thr Ala Asp Cys Lys Thr Ala 
1               5                   10                  15      


Val Asn Cys Ser Ser Asp Phe Asp Ala Cys Leu Ile Thr Lys Ala Gly 
            20                  25                  30          


Leu Gln Val Tyr Asn Lys Cys Trp Lys Phe Glu His Cys Asn Phe Asn 
        35                  40                  45              


Asp Val Thr Thr Arg Leu Arg Glu Asn Glu Leu Thr Tyr Tyr Cys Cys 
    50                  55                  60                  


Lys Lys Asp Leu Cys Asn Phe Asn Glu Gln Leu Glu Asn 
65                  70                  75          


<210>  2
<211>  27
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  2

Phe Glu His Cys Asn Phe Asn Asp Val Thr Thr Arg Leu Arg Glu Asn 
1               5                   10                  15      


Glu Leu Thr Tyr Tyr Cys Cys Lys Lys Asp Leu 
            20                  25          


<210>  3
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  3

Phe Glu His Cys Asn Phe Asn Asp Val Thr Thr Arg Leu Arg Glu Asn 
1               5                   10                  15      


Glu Leu Thr Tyr Tyr Cys Cys Lys Lys 
            20                  25  


<210>  4
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  4

His Cys Asn Phe Asn Asp Val Thr Thr Arg Leu Arg Glu Asn Glu Leu 
1               5                   10                  15      


Thr Tyr Tyr Cys Cys Lys Lys 
            20              


<210>  5
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  5

Ala Cys Asn Phe Asn Asp Val Thr Thr Arg Leu Arg Glu Asn Glu Leu 
1               5                   10                  15      


Thr Tyr Tyr Cys Ala Ala Lys 
            20              


<210>  6
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  6

Ala Phe Glu His Cys Asn Phe Asn Asp Val Thr Thr Arg Leu Arg Glu 
1               5                   10                  15      


Asn Glu Leu Thr Tyr Tyr Cys Ala Ala Lys Asp Leu 
            20                  25              


<210>  7
<211>  27
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  bAla

<400>  7

Ala Phe Glu His Cys Asn Phe Asn Asp Val Thr Thr Arg Leu Arg Glu 
1               5                   10                  15      


Asn Glu Leu Thr Tyr Tyr Cys Xaa Lys Asp Leu 
            20                  25          


<210>  8
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct


<220>
<221>  MOD_RES
<222>  (24)..(24)
<223>  Aib

<400>  8

Ala Phe Glu His Cys Asn Phe Asn Asp Val Thr Thr Arg Leu Arg Glu 
1               5                   10                  15      


Asn Glu Leu Thr Tyr Tyr Cys Xaa Ala Lys Asp Leu 
            20                  25              


<210>  9
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  9

Asn Lys Cys Trp Lys Phe Glu His Cys Asn Phe Asn Asp Val 
1               5                   10                  


<210>  10
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  10

Asn Lys Ala Trp Lys Phe Glu His Ala Asn Phe Asn Asp 
1               5                   10              


<210>  11
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  11

Asn Lys Ala Trp Lys Phe Glu His Ala Asn Phe Asn Asp Cys 
1               5                   10                  


